Tom Schnettler is vice chairman of Piper Sandler Companies, president of Piper Sandler Investment Group, a managing director in the merchant banking group, a member of the general partner and serves on the investment committee. He initiated the merchant banking business at Piper Sandler in 2008 and has overseen the division since that time. Schnettler also served as president and chief operating officer of Piper Sandler from 2008 to 2011, and as chief financial officer between 2006 and 2008. Prior to that, Schnettler served as head of the Piper Sandler corporate and institutional services business beginning in 2002, and as head/co-head of investment banking beginning in 2000. From 1989 to 2000, he co-founded and led the healthcare investment banking group. Schnettler joined the Piper Sandler investment banking group in 1986.
Schnettler has served on the board of, or held board observation responsibility for, the following portfolio companies: Torax Medical, Sapphire Digital, OrthoAccel, Sport Ngin, Xenex Disinfection Services, Elligo Health Research, Akoya Biosciences, Paragon 28, Moxe Health and Integrity Orthopaedics. Over the course of his career, he has served many nonprofit organizations including Saint John’s University, The Lillehei Heart Institute at the University of Minnesota, Catholic Charities of St. Paul and Minneapolis and the American Heart Association.
Schnettler graduated from Saint John’s University in Collegeville, Minnesota, and holds a Juris doctorate from Harvard Law School.
Merchant Banking Growth Equity Funds are managed by PSC Capital Partners LLC, an SEC-registered investment adviser.